Presentation is loading. Please wait.

Presentation is loading. Please wait.

Melagatran for thromboprophylaxis after mechanical valve implantation: Results in a heterotopic porcine model  Jess L. Thompson, MD, Chad E. Hamner, MD,

Published byRosamund Goodman Modified over 5 years ago

Similar presentations

Presentation on theme: "Melagatran for thromboprophylaxis after mechanical valve implantation: Results in a heterotopic porcine model  Jess L. Thompson, MD, Chad E. Hamner, MD,"— Presentation transcript:

1 Melagatran for thromboprophylaxis after mechanical valve implantation: Results in a heterotopic porcine model  Jess L. Thompson, MD, Chad E. Hamner, MD, D. Dean Potter, MD, Matthew Lewin, MD, Thoralf M. Sundt, MD, Hartzell V. Schaff, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 134, Issue 2, Pages (August 2007) DOI: /j.jtcvs Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 Cartoon depicting the heterotopic model. A valved graft has been implanted onto the aorta, with diversion of the bloodstream through the conduit by ligation of the aorta. (Used with permission of Mayo Foundation for Medical Education and Research.) The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

3 Figure 2 Photographs illustrating thrombus accumulation on the explanted valves 30 days after implantation in animals receiving melagatran (A), dalteparin (B), or no anticoagulation therapy (C). Visual inspection shows that both melagatran and dalteparin decrease thrombus formation. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

4 Figure 2 Photographs illustrating thrombus accumulation on the explanted valves 30 days after implantation in animals receiving melagatran (A), dalteparin (B), or no anticoagulation therapy (C). Visual inspection shows that both melagatran and dalteparin decrease thrombus formation. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

5 Figure 3 Box plots showing median (interquartile range) thrombus weight for the melagatran, dalteparin, and control groups. (Melagatran vs dalteparin and control, P = .04.) The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions

Download ppt "Melagatran for thromboprophylaxis after mechanical valve implantation: Results in a heterotopic porcine model  Jess L. Thompson, MD, Chad E. Hamner, MD,"

Similar presentations

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 

Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Of mice and men and surgical transcatheter aortic valve insertion

Of mice and men and surgical transcatheter aortic valve insertion
Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Can papillary muscle interventions improve mitral valve repair durability for ischemic mitral regurgitation?  Christos G. Mihos, DO, Orlando Santana,

Can papillary muscle interventions improve mitral valve repair durability for ischemic mitral regurgitation?  Christos G. Mihos, DO, Orlando Santana,
Stephen H. McKellar, MD, MSc, Stuart Abel, BS, Christopher L

Stephen H. McKellar, MD, MSc, Stuart Abel, BS, Christopher L
Ultrasound, endoscopy, and the recurrent nerve

Ultrasound, endoscopy, and the recurrent nerve
Replacement of the ascending aorta in bicuspid aortic valve disease: Where do we draw the line?  Thoralf M. Sundt, MD  The Journal of Thoracic and Cardiovascular.

Replacement of the ascending aorta in bicuspid aortic valve disease: Where do we draw the line?  Thoralf M. Sundt, MD  The Journal of Thoracic and Cardiovascular.
Improving health care by embracing Systems Theory

Improving health care by embracing Systems Theory
Harold M. Burkhart, MD, Jeffrey B. Riley, CCP, Sarah E

Harold M. Burkhart, MD, Jeffrey B. Riley, CCP, Sarah E
The days of future past  Neel K. Ranganath, MD, Aubrey C. Galloway, MD 

The days of future past  Neel K. Ranganath, MD, Aubrey C. Galloway, MD 
Anticoagulation early after mechanical valve replacement: Improved management with patient self-testing  Jess L. Thompson, MD, Harold M. Burkhart, MD,

Anticoagulation early after mechanical valve replacement: Improved management with patient self-testing  Jess L. Thompson, MD, Harold M. Burkhart, MD,
Right internal thoracic artery or saphenous vein grafting

Right internal thoracic artery or saphenous vein grafting
Intrinsic cardiac stem cells are essential for regeneration

Intrinsic cardiac stem cells are essential for regeneration
Abracadabra I, II…HeartMate 3?

Abracadabra I, II…HeartMate 3?
Form ever follows function

Form ever follows function
Victor van Berkel, MD, PhD 

Victor van Berkel, MD, PhD 
Quadruple valve replacement in patients with carcinoid heart disease

Quadruple valve replacement in patients with carcinoid heart disease
Bicuspid aortic valve aortopathy: One size fits all?

Bicuspid aortic valve aortopathy: One size fits all?
Bigger The Journal of Thoracic and Cardiovascular Surgery

Bigger The Journal of Thoracic and Cardiovascular Surgery

Similar presentations

Ads by Google